American Heart Association (AHA): Scientific Sessions 2025 Highlights
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
The American Heart Association (AHA) Scientific Sessions is an annual, four-day conference that brings together cardiovascular healthcare professionals from around the world to share the latest advances, research, and guidelines in heart and vascular medicine.
AHA 2025 took place in New Orlkeans, Louisiana, between 7-10 November 2025.
GlobalData's cardiovascular & metabolic team attended industry-sponsored and scientific sessions where key therapies were featured, the contents of which were analyzed to create this AHA 2025 Highlights report.
Scope
Indications, companies, and therapies discussed –
›GLP-1RAs
›Novo Nordisk – Semaglutide
›Viking Therapeutics – VK2735
›Hyperlipidemia
›SHR-1918
›Heart Failure
›BacNav
›Pulmonary Arterial Hypertension
›Satralizumab
›And more!
Reasons to Buy
This powerpoint-based deliverable provides analysis on key presentations from the conference, and what they mean for your strategy, covering disease areas such as Obesity, Heart Failure, Pulmonary Arterial Hypertension, Dyslipidemia, and more.
Inside the report you’ll find –
• Emerging trends in cardiovascular and metabolic indications
• Insights into the disease areas that took precedence at the conference
• Key takeaways from headline sessions and late-breaking data
• Clinical and commercial implications of notable presentations
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Pharmaceuticals reports